Influence of the Design of the Transmucosal Abutment on the Periimplant Bone Level
1 other identifier
interventional
36
1 country
1
Brief Summary
The objective of this study is to evaluate the radiographic changes on the marginal peri-implant bone level on bone level implants with a narrower transmucosal abutment, in comparison to the conventional abutment, both of 3mm height
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 6, 2020
CompletedFirst Posted
Study publicly available on registry
May 12, 2020
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedSeptember 29, 2021
September 1, 2021
1 month
May 6, 2020
September 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Radiographic marginal periimplant bone level changes
Measured as the distance from the bone crest to the first implant-to-bone contact. This will be assessed on parallelized periapical radiographies
from baseline (connection of the definitive abutment) to 6 and 12 months after the definitive prostheses will be connected, and finally 3 years later
Secondary Outcomes (6)
Probing pocket depth
6 and 12 months after the definitive prostheses will be connected, and finally 3 years later
Papilla refill
6 and 12 months after the definitive prostheses will be connected, and finally 3 years later
Bleeding on probing
6 and 12 months after the definitive prostheses will be connected, and finally 3 years later
Plaque index
6 and 12 months after the definitive prostheses will be connected, and finally 3 years later
Patient Reported Outcomes Measurements
6 and 12 months after the definitive prostheses will be connected, and finally 3 years later
- +1 more secondary outcomes
Study Arms (2)
Control Group
OTHERControl group will receive an intermediate transmucosal abutment with conventional diameter and 3mm height, once the implants are placed.
Test Group
EXPERIMENTALTest group will receive an intermediate transmucosal abutment with a TCP design, narrower than the conventional one, of 3mm height, once the implants are placed
Interventions
The macroscopic design of the intermediate transmucosal abutment will be evaluated on terms of the marginal peri-implant bone levels using two identical devices, if only being the test device narrower than the control one
The macroscopic design of the intermediate transmucosal abutment will be evaluated on terms of the marginal peri-implant bone levels using two identical devices, if only being the test device narrower than the control one
Eligibility Criteria
You may qualify if:
- Absence of systemic and periodontal pathology, over 18 years of age, with a plaque index below 25%.
- Absence of at least one tooth, with natural adjacent teeth, allowing a prosthetic rehabilitation with an osseointegrated implant and a prosthetic unit.
- Adequate bone quality available, allowing placement of MOZO GRAU® implants InHex STD QUATTRO with diameters of 3.75 mm or 4.25 mm and lengths of 8, 10 and 11.5 mm.
- Natural teeth or implants with fixed restoration as antagonists.
You may not qualify if:
- Systemic factors:
- Continuous administration of systemic medication that can interfere with the bone metabolism or medical conditions requiring prolonged use of steroids and / or medications that can interfere with bone metabolism.
- History of leukocyte dysfunction and deficiency, immunodeficiency syndromes, kidney failure or bone metabolic disorders, such as osteoporosis.
- Physical disability that may interfere with proper oral hygiene.
- Use of any investigational medication or device within the previous 30 days to implant surgery in the study.
- Alcoholism or drug addiction
- Smoker of more than 10 cigarettes per day.
- Conditions or circumstances that could prevent compliance with participation in study or interfere with the analysis of results, such as a history of breach or unreliability.
- Local factors:
- History of local radiotherapy.
- Bruxism.
- Diseases that affect the oral mucosa, such as oral lichen planus.
- Untreated periodontitis.
- Persistent intraoral infection.
- Post-extraction alveoli not cured (less than 6 weeks after extraction).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Santiago de Compostelalead
- Mozo Grau Ticare Implantscollaborator
Study Sites (1)
University of Santiago de Compostela
Santiago de Compostela, La Coruña, 15782, Spain
Related Publications (7)
Alves CC, Munoz F, Cantalapiedra A, Ramos I, Neves M, Blanco J. Marginal bone and soft tissue behavior following platform switching abutment connection/disconnection--a dog model study. Clin Oral Implants Res. 2015 Sep;26(9):983-91. doi: 10.1111/clr.12385. Epub 2014 Apr 16.
PMID: 24735458BACKGROUNDBerglundh T, Lindhe J. Dimension of the periimplant mucosa. Biological width revisited. J Clin Periodontol. 1996 Oct;23(10):971-3. doi: 10.1111/j.1600-051x.1996.tb00520.x.
PMID: 8915028BACKGROUNDBlanco J, Pico A, Caneiro L, Novoa L, Batalla P, Martin-Lancharro P. Effect of abutment height on interproximal implant bone level in the early healing: A randomized clinical trial. Clin Oral Implants Res. 2018 Jan;29(1):108-117. doi: 10.1111/clr.13108. Epub 2017 Dec 8.
PMID: 29222809BACKGROUNDEricsson I, Persson LG, Berglundh T, Marinello CP, Lindhe J, Klinge B. Different types of inflammatory reactions in peri-implant soft tissues. J Clin Periodontol. 1995 Mar;22(3):255-61. doi: 10.1111/j.1600-051x.1995.tb00143.x.
PMID: 7790533BACKGROUNDKoutouzis T, Adeinat B, Ali A. The influence of abutment macro-design on clinical and radiographic peri-implant tissue changes for guided, placed, and restored implants: A 1-year randomized controlled trial. Clin Oral Implants Res. 2019 Sep;30(9):882-891. doi: 10.1111/clr.13493. Epub 2019 Jun 24.
PMID: 31180160BACKGROUNDNovoa L, Batalla P, Caneiro L, Pico A, Linares A, Blanco J. Influence of Abutment Height on Maintenance of Peri-implant Crestal Bone at Bone-Level Implants: A 3-Year Follow-up Study. Int J Periodontics Restorative Dent. 2017 Sep/Oct;37(5):721-727. doi: 10.11607/prd.2762.
PMID: 28817138BACKGROUNDSouza AB, Alshihri A, Kammerer PW, Araujo MG, Gallucci GO. Histological and micro-CT analysis of peri-implant soft and hard tissue healing on implants with different healing abutments configurations. Clin Oral Implants Res. 2018 Oct;29(10):1007-1015. doi: 10.1111/clr.13367. Epub 2018 Sep 23.
PMID: 30246409BACKGROUND
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- None of the participants or the outcomes assessor will know the device (transmucosal abutment) received. The care provider will connect the transmucosal abutment while the surgery, after opening the randomization envelope; and the investigator will identify the participant's group while analysing the radiographs.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 6, 2020
First Posted
May 12, 2020
Study Start
October 1, 2024
Primary Completion
October 31, 2024
Study Completion
November 1, 2024
Last Updated
September 29, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share